Pictured: Sign at Pfizers headquarters in New York/iStock, JHVEPhoto Pfizer on Friday said it is scrapping an investigational twice-daily oral Glucagon-like peptide-1 receptor agonist candidate after topline data from a Phase IIb trial of obese patients without type 2 diabetes showed high rates of adverse events
Over-the-counter (OTC) options, such asdimenhydrinate (Dramamine), and prescription medications , such as ondansetron (Zofran) and metoclopramide (Reglan), may be useful
11,12 The BMJ guideline differs somewhat from other organizations
Semaglutide Storage and Administration Does Semaglutide go bad
This is general education, not a prescription
The study found that those taking semaglutide medication over a ten-year period reduced their risk of later developing cirrhosis of the liver and liver cancer by 50 percent